The treatment landscape of resectable early-stage non-small cell lung cancer (NSCLC) is
transforming due to the approval of novel adjuvant and neoadjuvant systemic treatments …

The treatment landscape of resectable early-stage non-small cell lung cancer (NSCLC) is
set to change significantly due to encouraging results from randomized trials evaluating …

Rationale: Altered pulmonary hemodynamics and fluid flow–induced high shear stress
(HSS) are characteristic hallmarks in the pathogenesis of pulmonary arterial hypertension …

Background: Once recurrent or persistent locoregional tumour after radical
chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC) is identified, few curative …

Rationale: von Willebrand factor (vWF) mediates platelet adhesion during thrombosis. While
chronic thromboembolic pulmonary hypertension (CTEPH) is associated with increased …

Background: Traditionally, surgical resection is the preferred treatment for typical carcinoids
and atypical carcinoids located in the lungs. Recently however, several studies have shown …

Importance Hypoparathyroidism is one of the most common complications after total or
completion thyroidectomy. The reported incidence rate of hypoparathyroidism in the …

Imbalanced transforming growth factor beta (TGFβ) and bone morphogenetic protein (BMP)
signaling are postulated to favor a pathological pulmonary endothelial cell (EC) phenotype …

Aims Pulmonary arterial hypertension (PAH) is associated with increased levels of
circulating growth factors and corresponding receptors such as platelet derived growth …

Background The likelihood of a tumor recurrence in patients with T3-4N0–1 non-small cell
lung cancer following multimodality treatment remains substantial, mainly due distant …